par Esme Fowler-Mason | Déc 9, 2024 | Access to Care, NCD Policy, Actualités
Access to essential treatments is a cornerstone of effective healthcare systems. Both brand-name medicines and generics play vital roles in ensuring that patients receive the care they need. While brand-name medicines are often associated with innovation and...
par Esme Fowler-Mason | Déc 9, 2024 | Access to Care, NCD Financing, Actualités
Success in improving access to cancer care is not about a one-size-fits-all approach; it involves addressing unmet needs with high-impact actions. In its comprehensive white paper, Improving Access to Affordable and Sustainable Oncological Care in Africa, IQVIA...
par Esme Fowler-Mason | Nov 19, 2024 | Healthcare Systems, NCD Policy, Actualités
“Localisation.” It’s a term we’ve heard frequently in recent years, but not without its critics—and perhaps rightly so. Many argue that “localisation” doesn’t fully capture the essence of legitimising communities to lead their own health solutions, often implying a...
par Esme Fowler-Mason | Sep 9, 2024 | NCD Financing, NCD Policy, Actualités
Over the past two decades, noncommunicable diseases (NCDs) and mental health have evolved from niche concerns in global health to central pillars of the sustainable development agenda. Since the 2011 High-level Meeting on the Prevention and Control of NCDs,...
par Callie Weber | Avr 15, 2024 | Access to Care, NCD Partnerships, Actualités
IDA Foundation and FIND have joined forces to help address the challenges of availability, affordability, and optimal use of diagnostics for Noncommunicable Diseases (NCDs) in low- and middle-income countries (LMICs). IDA Foundation and FIND Partner to Deliver NCD...
par Callie Weber | Mar 13, 2024 | Access to Care, NCD Partnerships, Actualités
In a significant stride towards addressing the global challenge of Noncommunicable Diseases (NCDs), IDA Foundation and the Coalition for Access to NCD Medicines & Products are proud to announce their partnership. NCDs, encompassing chronic conditions such as...
